Mumbai, India: Fischer Medical Ventures Limited (FMVL) today announced that its strategic partner, Nanyang Biologics, has achieved a significant international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by
Fischer Medical Ventures Ltd. (Fischer MV), a pioneering force in the healthcare industry, has signed a Memorandum of Understanding with Tech Avant-Garde (TAG), an innovative educational solutions provider, to implement comprehensive health programs in educational institutions across India. This strategic partnership aims to drive holistic
Fischer Medical Ventures Limited’s (formerly known as Fischer Chemic Limited) wholly owned subsidiary - Time Medical International Ventures (India) Private Limited, and a Singapore-based company Nervotec Pte Ltd (Nervotec), firm up global partnership to revolutionize healthcare screening through contactless video-based vital signs monitoring. Fischer Medical Ventures
